Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human GLUT5 specific inhibitors and methods of treatment

Human GLUT5 specific inhibitors and methods of treatment

US Patent 10822325 · Granted Nov 3, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds for selective binding to estrogen receptors alpha/beta relative to GPE2025
Modulators of GTPases and their use2025
Modulators of GTPases and their use2023
Modulators of GTPases and their use2020
Modulators of GTPase and use in relevant treatment2017
Methods and related compositions for the treatment of cancer2016
Modulators of GTPases and their use2015
Methods for reducing superoxide anions in eukaryotic organisms2015
Bifunctional metnase/intnase inhibitors and related compositions and methods of 2014
Methods and related compositions for the treatment of cancer2014
Compounds for binding to ER alpha/beta and GPR30, methods of treating disease st2013
Compounds for binding to ER alpha/beta and GPR30, methods of treating disease st2013